Table 4 Application of the proposed method to the analysis of diclofenac and methocarbamol in Methoquick® tablets.
Parameters | Diclofenac | Methocarbamol | ||||
|---|---|---|---|---|---|---|
Conc. Taken (µg/mL) | %found | Comparison method | Conc. Taken (µg/mL) | %found | Comparison method | |
Methoquick® tablets | 0.3 | 99.69 | 100.5 | 3.0 | 99.71 | 100.55 |
0.35 | 100.27 | 99.82 | 3.5 | 98.63 | 100.07 | |
0.4 | 99.76 | 99.61 | 4.0 | 99.99 | 99.75 | |
0.45 | 100.62 | 99.82 | 4.5 | 99.78 | 99.18 | |
0.5 | 99.63 | 100.31 | 5.0 | 101.42 | 100.54 | |
Mean ± SD | 99.99 ± 0.43 | 100.012±0.38 | 99.9 ± 0.99 | 100.018±0.58 | ||
t test | 0.957 (2.776)* | 0.812 (2.776)* | ||||
F test | 1.280 (6.388)* | 2.913 (6.388)* | ||||